Vanguard Personalized Indexing Management
ANRO icon

Vanguard Personalized Indexing Management’s Alto Neuroscience ANRO Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$334K Sell
12,658
-2,988
-19% -$69.1K ﹤0.01% 1640
2026
Q1 		$352K Sell
15,646
-839
-5% -$15.6K ﹤0.01% 1515
2025
Q4 		$293K Sell
16,485
-560
-3% -$7.05K ﹤0.01% 1534
2025
Q3 		$68.5K Buy
17,045
+2,055
+14% +$6.81K ﹤0.01% 1870
2025
Q2 		$33K Buy
+14,990
New +$35.7K ﹤0.01% 1865

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Personalized Indexing Management's ANRO Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Alto Neuroscience (ANRO) stake by 19% in Q2 2026, selling an estimated $69.1K and leaving 12,658 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Vanguard Personalized Indexing Management first reported a position in ANRO in Q2 2025 and has held it in 5 quarters since. The position peaked at $352K in Q1 2026. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Vanguard Personalized Indexing Management held 12,658 shares of Alto Neuroscience worth $334K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 2,988 Alto Neuroscience shares in Q2 2026, an estimated $69.1K.
  • Alto Neuroscience made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1640 holding.
  • Vanguard Personalized Indexing Management first reported a position in Alto Neuroscience in Q2 2025 and has held it in 5 quarters since.
  • Vanguard Personalized Indexing Management's Alto Neuroscience position peaked at $352K in Q1 2026.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.